| Tuesday 21 January 2025 |
| Time |
Session |
| 08.30-12.00 |
Session 2: Subtyping patient populations
Chair: Peter Falkai, Germany |
| 08.30-09.00 |
1. Diagnostic formulations in precisions psychiatry
Speaker: Maria Oquendo, United States |
| 09.00-09.30 |
2. Brain-derived measures for psychosis biotyping
Speaker: Carol Tamminga, United States |
09.30-10.00
|
3. Neuro-imaging markers for precision psychiatry: depression as an example
Speaker: Nikolaos Koutsouleris, Germany
|
| 10.00-10.30 |
Coffee break |
10.30-11.00
|
4. Multimodal biomarkers
Speaker: Gitte Knudsen, Denmark
|
11.00-12.00
|
Panel discussion with speakers and a representative of the European Medical Agency
Ewa Bałkowiec-Iskra, Poland
|
| 12.00-12.45 |
Lunch |
12.45-15.00
|
Session 3: Targeted interventions in stratified patient groups
Chair: Andreas Reif, Germany
|
12.45-13.15
|
1. Immuno-metabolic depression: strategies and treatment options
Speaker: Brenda Penninx, Netherlands
|
13.15-13.45
|
2. Patient stratification and psychotherapy
Speaker: Frank J. Padberg, Germany
|
13.45-14.15
|
3. The future of precision psychiatry: an industry perspective
Speaker: Wayne C. Drevets, United States
|
| 14.15-14.55 |
Panel discussion with speakers, a patient representative Shaun Johnson, United Kingdom, payers’ representative |
| 14.55-15.00 |
Conclusions and closing words
|
